Original Research

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective

Dranitsaris G, Yu B, King J, Kaura S, Zhang A

ClinicoEconomics and Outcomes Research 2015, 7:249-256

Published Date: 12 May 2015